Literature DB >> 27770485

3,5-diiodothyronine (3,5-T2) reduces blood glucose independently of insulin sensitization in obese mice.

S da Silva Teixeira1,2, C Filgueira2, D H Sieglaff2, C Benod2, R Villagomez2, L J Minze2, A Zhang2, P Webb2, M T Nunes1.   

Abstract

AIM: Thyroid hormones regulate metabolic response. While triiodothyronine (T3) is usually considered to be the active form of thyroid hormone, one form of diiodothyronine (3,5-T2) exerts T3-like effects on energy consumption and lipid metabolism. 3,5-T2 also improves glucose tolerance in rats and 3,5-T2 levels correlate with fasting glucose in humans. Presently, however, little is known about mechanisms of 3,5-T2 effects on glucose metabolism. Here, we set out to compare effects of T3, 3,5-T2 and another form of T2 (3,3-T2) in a mouse model of diet-induced obesity and determined effects of T3 and 3,5-T2 on markers of classical insulin sensitization to understand how diiodothyronines influence blood glucose.
METHODS: Cell- and protein-based assays of thyroid hormone action. Assays of metabolic parameters in mice. Analysis of transcript and protein levels in different tissues by qRT-PCR and Western blot.
RESULTS: T3 and 3,5-T2 both reduce body weight, adiposity and body temperature despite increased food intake. 3,3'-T2 lacks these effects. T3 and 3,5-T2 reduce blood glucose levels, whereas 3,3'-T2 worsens glucose tolerance. Neither T3 nor 3,5-T2 affects markers of insulin sensitization in skeletal muscle or white adipose tissue (WAT), but both reduce hepatic GLUT2 glucose transporter levels and glucose output. T3 and 3,5-T2 also induce expression of mitochondrial uncoupling proteins (UCPs) 3 and 1 in skeletal muscle and WAT respectively.
CONCLUSIONS: 3,5-T2 influences glucose metabolism in a manner that is distinct from insulin sensitization and involves reductions in hepatic glucose output and changes in energy utilization.
© 2016 Scandinavian Physiological Society. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  blood glucose; diiodothyronine; insulin response; metabolism; thyroid hormone; thyromimetic

Mesh:

Substances:

Year:  2016        PMID: 27770485     DOI: 10.1111/apha.12821

Source DB:  PubMed          Journal:  Acta Physiol (Oxf)        ISSN: 1748-1708            Impact factor:   6.311


  17 in total

1.  Emerging Pharmacological Targets for the Treatment of Nonalcoholic Fatty Liver Disease, Insulin Resistance, and Type 2 Diabetes.

Authors:  Leigh Goedeke; Rachel J Perry; Gerald I Shulman
Journal:  Annu Rev Pharmacol Toxicol       Date:  2019-01-06       Impact factor: 13.820

Review 2.  Novel thyroid hormones.

Authors:  Riccardo Zucchi; Grazia Rutigliano; Federica Saponaro
Journal:  Endocrine       Date:  2019-07-20       Impact factor: 3.633

Review 3.  Thyroid hormone metabolites and analogues.

Authors:  Rosalba Senese; Federica Cioffi; Giuseppe Petito; Fernando Goglia; Antonia Lanni
Journal:  Endocrine       Date:  2019-07-29       Impact factor: 3.633

4.  Both 3,5-Diiodo-L-Thyronine and 3,5,3'-Triiodo-L-Thyronine Prevent Short-term Hepatic Lipid Accumulation via Distinct Mechanisms in Rats Being Fed a High-Fat Diet.

Authors:  Rosalba Senese; Federica Cioffi; Pieter de Lange; Cristina Leanza; Liliana F Iannucci; Elena Silvestri; Maria Moreno; Assunta Lombardi; Fernando Goglia; Antonia Lanni
Journal:  Front Physiol       Date:  2017-09-14       Impact factor: 4.566

5.  3,5-Diiodo-L-Thyronine Affects Structural and Metabolic Features of Skeletal Muscle Mitochondria in High-Fat-Diet Fed Rats Producing a Co-adaptation to the Glycolytic Fiber Phenotype.

Authors:  Elena Silvestri; Federica Cioffi; Rita De Matteis; Rosalba Senese; Pieter de Lange; Maria Coppola; Anna M Salzano; Andrea Scaloni; Michele Ceccarelli; Fernando Goglia; Antonia Lanni; Maria Moreno; Assunta Lombardi
Journal:  Front Physiol       Date:  2018-03-09       Impact factor: 4.566

6.  Beneficial effects of thyroid hormone on adipose inflammation and insulin sensitivity of obese Wistar rats.

Authors:  Ana C Panveloski-Costa; Caroline Serrano-Nascimento; Paula Bargi-Souza; Leonice L Poyares; Gabriela de S Viana; Maria T Nunes
Journal:  Physiol Rep       Date:  2018-02

Review 7.  Thyroid Hormones, Thyromimetics and Their Metabolites in the Treatment of Liver Disease.

Authors:  Marta A Kowalik; Amedeo Columbano; Andrea Perra
Journal:  Front Endocrinol (Lausanne)       Date:  2018-07-10       Impact factor: 5.555

Review 8.  The role of thyroid hormone in metabolism and metabolic syndrome.

Authors:  Patrícia de Fátima Dos Santos Teixeira; Patrícia Borges Dos Santos; Carmen Cabanelas Pazos-Moura
Journal:  Ther Adv Endocrinol Metab       Date:  2020-05-13       Impact factor: 3.565

Review 9.  Similarities and Differences in the Peripheral Actions of Thyroid Hormones and Their Metabolites.

Authors:  Ruy A Louzada; Denise P Carvalho
Journal:  Front Endocrinol (Lausanne)       Date:  2018-07-19       Impact factor: 5.555

Review 10.  Genomic and Non-Genomic Mechanisms of Action of Thyroid Hormones and Their Catabolite 3,5-Diiodo-L-Thyronine in Mammals.

Authors:  Marco Giammanco; Carlo Maria Di Liegro; Gabriella Schiera; Italia Di Liegro
Journal:  Int J Mol Sci       Date:  2020-06-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.